Physician profile
Aditya Chada
NPI 1245660257
$691.52
in general payments reported to CMS, 2019-2025
10 companies · $60.48 in 2025
The $60.48 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2022: $154 · 2023: $183 · 2024: $169 · 2025: $60.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $395 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $394.92 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $142.20 | 2022-2025 | Diamondback Coronary |
| Inari Medical, INC. | $130.23 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Eisai INC. | $125.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.89 | 2023 | Jardiance |
| Boston Scientific Corporation | $91.24 | 2023 | Watchman Access System |
| Insmed, INC. | $36.41 | 2025 | Brinsupri, Arikayce |
| United Therapeutics Corporation | $21.70 | 2024 | Tyvaso |
| Vapotherm INC | $20.63 | 2022 | |
| Resmed Corp | $16.76 | 2024 | |
| Edwards Lifesciences Corporation | $15.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aditya Chada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.